LINK:  Telephone #:  415-655-0003    Access #:  2597 587 8610    Password:  Lecture     

 OBJECTIVES: Upon completion of this activity, the participant should be able to - (1) Describe which classes of immunosuppression attenuate humoral responses following SARS-CoV-2 vaccination, (2) Describe how boosting can influence both antibody and neutralization responses.

FACULTY DISCLOSURE:  Alfred Kim, MD, PhD is either on the speakers’ bureau, research support, and/or a consultant for GlaxoSmithKline, Foghorn Therapeutics, Alexion Pharmaceutical, Aurinia Pharmaceutical, and Exagen Diagnostics. 

PLANNER DISCLOSURE:  John D. Myers, MD and Tresa McNeal, MD, have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC:  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For information, please contact Denise Ralston at [email protected]